Monday, September 26, 2011
The Republicans' presidential debate Thursday night sponsored by Fox News and Google gave primary voters and caucus-goers at least one good reason to reject every candidate on the stage. The interesting question now is whether someone else will enter the race -- at just about the same point in the election cycle in which Bill Clinton entered the Democratic race in 1991.
The spotlight was hottest on Rick Perry, the frontrunner in national polls since he announced his candidacy in Charleston, S.C., on Aug. 13, the same day that Michele Bachmann won the straw poll in Ames, Iowa.
Perry's problem was not just that he punted on the tough question of how to respond to a terrorist takeover of nuclear-armed Pakistan. Even the smooth-talking Mitt Romney might have had trouble with that nightmare scenario. And Perry was right to cite our informal alliance with India as a source of leverage.
The problem was that Perry was couldn't respond cogently to utterly predictable questions and was unable to articulate his pre-scripted criticisms of Romney. A case can certainly be made that Romney has flip-flopped on issues. But Perry failed to make it.
Perry defended his order requiring HPV vaccinations by citing his talks with a woman with cervical cancer -- but they took place only after his order. He failed to fend off attacks on his criticisms of Social Security in his book "Fed Up!," saying he was only endorsing the longtime exemption from the program for state and local public employees.
He failed to explain why Texas, with its large legal and illegal immigrant and young populations, has a high percentage of people without health insurance.
He was eloquent in defending Texas's in-state college tuition for children of illegal aliens, but his stand is hugely unpopular with Republicans outside Texas. And he failed to point out that it helped him win a respectable 38 percent from Latino voters in the 2010 election.
Mitt Romney clearly benefited from his greater experience over the years and his superior preparation in recent weeks. But he also benefited from the fact that no one challenged him convincingly on claims that he is unlikely to be able to sustain.
He sloughed off Perry's accurate charge that he supported the Obama administration's Race to the Top education program -- a defensible position, but not a popular one for Republicans.
He repeated now what has been his standard defense of his Massachusetts health care program. But someday someone is going to nail him on his insistence that its individual mandate to buy insurance covers only 8 percent of the population. It actually applies to everyone.
He avoided Perry's claim that he deleted defenses of the program from the paperback edition of his book. He won't be able to deftly dodge that foreve
If he overtakes Perry in the polls -- a likely possibility after the Texan's stumbling performance -- he will likely become the pinata for the rest of the field, a role he figured to play before Perry entered the race.
None of the other seven candidates on the stage made a convincing case for advancing to the top tier. The closest was Rick Santorum, who was eloquent and knowledgeable on foreign policy. But his answer on gays in the military was cringe-inducing for people on all sides of the issue.
Michele Bachmann refused to back down from her statement relaying the claim of a woman who approached her saying that the HPV vaccine caused retardation in her child. Bachmann has made headway by championing the instincts of ordinary hardworking citizens over the supposed wisdom of experts. But on vaccinations the experts are right.
Pundits are fixated on designating a frontrunner, but the polls in this race -- witness Romney's rise and fall and Perry's rise -- have all the solidity of cotton candy. Bachmann's numbers peaked in July, Herman Cain's in June, Ron Paul's and Newt Gingrich's in May -- and not at high levels. Santorum's haven't peaked at all.
Could another candidate give a better performance than Perry and deliver more sustainable responses than Romney? To judge from their performances in various public and private venues the answer is yes for Mitch Daniels, Paul Ryan and Chris Christie.
Each has taken himself out of the race. Each still has time to get in. Most voters are ready to reject Barack Obama. But not necessarily for one of those on the stage Thursday night.
Michael Barone, senior political analyst for The Washington Examiner (www.washingtonexaminer.com), is a resident fellow at the American Enterprise Institute, a Fox News Channel contributor and a co-author of The Almanac of American Politics.
COPYRIGHT 2011 THE WASHINGTON EXAMINER
DISTRIBUTED BY CREATORS.COM
See Other Political Commentaries.
See Other Commentaries by Michael Barone.
Views expressed in this column are those of the author, not those of Rasmussen Reports. Comments about this content should be directed to the author or syndicate.
Rasmussen Reports is a media company specializing in the collection, publication and distribution of public opinion information.
We conduct public opinion polls on a variety of topics to inform our audience on events in the news and other topics of interest. To ensure editorial control and independence, we pay for the polls ourselves and generate revenue through the sale of subscriptions, sponsorships, and advertising. Nightly polling on politics, business and lifestyle topics provides the content to update the Rasmussen Reports web site many times each day. If it's in the news, it's in our polls. Additionally, the data drives a daily update newsletter and various media outlets across the country.
Some information, including the Rasmussen Reports daily Presidential Tracking Poll and commentaries are available for free to the general public. Subscriptions are available for $4.95 a month or 34.95 a year that provide subscribers with exclusive access to more than 20 stories per week on upcoming elections, consumer confidence, and issues that affect us all. For those who are really into the numbers, Platinum Members can review demographic crosstabs and a full history of our data.
To learn more about our methodology, click here.